I would be grateful if you could provide the following information relating to your ICB’s asthma/COPD pathways and associated formularies:
- The current review, renewal, or scheduled update date for any spacer device formulary recommendations used within your asthma/COPD pathway.
- The current review, renewal, or scheduled update date for any peak flow meter formulary recommendations used within your asthma/COPD pathway.
- Where applicable, the name of the committee, group, or governance body responsible for reviewing and approving these formulary decisions.
- The anticipated timeline for the next review of the spacer and peak flow sections of the formulary, if known.
- In addition, I would be grateful if you could provide the appropriate contact details for the individual(s) or team(s) responsible for receiving evidence and product information submissions relating to formulary reviews, including:
- Name
- Job title
- Email address
- Organisation/committee name
If any of the requested information is publicly available, please provide the relevant webpage link(s).
